RxDoctor Payments Data

Naohiro Shibuya, DPM

Foot & Ankle Surgery · Harlingen, TXNPI 1518976547

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.3%), other and speaking fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medshape, Inc. at 59.6% of the total. Reporting peaked in 2021 at $77,890 and has fallen 67.2% since, to $25,583 in 2025. Among foot & ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$184,879in general payments, 2019–2025

Across 139 payments — averaging $1330.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medshape, Inc.$110K
  • International Life Sciences$25K
  • Gramercy Extremity Orthopedics LLC$11K
  • Encore Medical, LP$11K
  • Synthes GmbH$10K
  • Trilliant Surgical LLC.$8K
  • plus $10K from 11 others
$1,250in research payments, 2019–2025

Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Metric Medical Devices, Inc.$1K
$50,000in ownership & investment interests, 2019–2025

Across 7 payments — averaging $7142.86 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$50K

What the payments were for

  • Royalty or licence$10,9486%
  • Consulting fees$81,95344%
  • Speaking & faculty fees$14,7438%
  • Travel & lodging$14,5698%
  • Food & beverage$2,5891%
  • Other$60,07732%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$184,879 in reported general payments places this provider in the 95th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$9,856
Medicare patients
35
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$105

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Harlingen

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →